The lancet oncology

• Latest
• Best
• Search…

• The lancet oncology · Sep 2020

  Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study.

  No standard treatment exists for advanced chordoma. Apatinib has been found to have promising efficacy and manageable adverse effects for the treatment of solid tumours. We aimed to investigate the safety and antitumour activity of apatinib in patients with advanced chordoma. ⋯ None.

  expand abstract… or not…

• The lancet oncology · Sep 2020

  Comment

  PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases.

  no abstract available

  explore more… mark as read…

• The lancet oncology · Sep 2020

  Editorial

  Acting on misinformation to prevent patient harm.

  no abstract available

  expand abstract… or not…

• The lancet oncology · Sep 2020

  Gender balance at oncology conferences in China.

  no abstract available

  explore further… or just mark as read…

• The lancet oncology · Sep 2020

  Comment

  Venetoclax plus obinutuzumab therapy for front-line treatment of chronic lymphocytic leukaemia.

  no abstract available

  keep reading… or not…